Save up -80% on Dalfopristin
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Synercid
|$410.03||1 vial/500 mg|
|price without discount in nearest pharmacy. Price may vary.|
We offer free Dalfopristin coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Dalfopristin every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Dalfopristin volume of distribution
The clearances of unchanged quinupristin and dalfopristin are similar (0.72 L/h/kg), and the steady-state volume of distribution for quinupristin is 0.45 L/kg and for dalfopristin is 0.24 L/kg. The elimination half-life of quinupristin and dalfopristin is approximately 0.85 and 0.70 hours, respectively.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Dalfopristin
Dalfopristin is a combination of two antibiotics (Dalfopristin and quinupristin used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium. It is not effective against Enterococcus faecalis infections. Dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome and quinupristin inhibits the late phase of protein synthesis.
Dalfopristin mechanism of action
The site of action of dalfopristin is the bacterial ribosome. Dalfopristin has been shown to inhibit the early phase of protein synthesis.
Dosage forms of Dalfopristin
|Injection, powder, lyophilized, for solution||intravenous|
|Powder for solution||intravenous|
Monarch Pharmaceuticals Ireland Limited
Enteric bacteria and other eubacteria
Indication of Dalfopristin
For the treatment of bacterial infections (usually in combination with quinupristin).
Toxicity of Dalfopristin
Synercid, dalfopristin, and quinupristin were all negative in the other four genetic toxicity assays. No impairment of fertility or perinatal/postnatal development was observed in rats at doses up to 12 to 18 mg/kg (approximately 0.3 to 0.4 times the human dose based on body-surface area).
RX24 Drugs Disclaimer: before buying a Dalfopristin on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.